Keywords: reneuron, losses, full, hit, l6, 3m, uk-based
ReNeuron's losses for full year 2005 hit L6.3M
Article | 10 July 2006
UK-based stem-cell specialists ReNeuron says that its losses for the year ended March 31, 2006, were L6.3 million ($11.6 million). The firm added ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
